Data Foundry

Drug recalls 2015

Gabapentin Capsules — Class II drug recall D-0336-2015

Terminated recall by Actavis Elizabeth LLC, reported 2015-01-14, distributed in PR. Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of caps

Recall numberD-0336-2015
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmActavis Elizabeth LLC, Elizabeth, NJ, United States
Recall initiated2014-12-15
Classified2015-01-08
Reported by FDA2015-01-14
Terminated2015-11-20
DistributedPR
Quantity10,857 bottles
Reason classeslabeling
NDC14550-0513-02, 45963-0555, 45963-0555-11, 45963-0555-50, 45963-0556, 45963-0556-11, 45963-0556-50, 45963-0557, 45963-0557-11, 45963-0557-50
Expiration dates2015-06, 2015-08

Product

Gabapentin Capsules, USP, 400 mg, Rx Only, a) 100 capsules per bottle, NDC 14550-513-02, b) 500 Capsules per bottle, NDC 45963-557-50, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA.

Reason for recall

Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0336-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.